PROCEPT BioRobotics (NASDAQ:PRCT – Free Report) had its target price hoisted by Truist Financial from $55.00 to $58.00 in a research note published on Wednesday, Benzinga reports. They currently have a buy rating on the stock. Separately, Wells Fargo & Company boosted their target price on shares of PROCEPT BioRobotics from $44.00 to $47.00 and […]
PROCEPT BioRobotics (NASDAQ:PRCT – Get Free Report) released its earnings results on Tuesday. The company reported ($0.54) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.44) by ($0.10), Briefing.com reports. The firm had revenue of $43.58 million during the quarter, compared to analysts’ expectations of $41.79 million. PROCEPT BioRobotics had a […]
Bio Stock Procept BioRobotics Approaches Rare Buy Trigger After Earnings investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.
27.02.2024 - SAN JOSE, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) - PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported .
Massachusetts Financial Services Co. MA grew its holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) by 0.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 678,027 shares of the company’s stock after purchasing an additional 1,155 shares during the period. Massachusetts Financial Services […]